Thioimidazoline based compounds reverse glucocorticoid resistance in human acute lymphoblastic leukemia xenografts1. Issue 22 (14th June 2015) - Toscan, Cara E.
Abstract Glucocorticoids form a critical component of chemotherapy regimens for pediatric acute lymphoblastic leukemia and initial poor response to glucocorticoid therapy is predictive of inferior outcome.